Empowered Funds
FHTX icon

Empowered Funds’s Foghorn Therapeutics FHTX Stock Holding History

Empowered Funds’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$252K Buy
+70,500
New +$371K ﹤0.01% 2121

Other funds holding FHTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Empowered Funds's FHTX Position: Q3 2026 in Review

Empowered Funds opened a new position in Foghorn Therapeutics (FHTX) in Q3 2026: 70,500 shares worth $252K. The stake represents ﹤0.01% of the portfolio and ranks #2121 among its holdings.

76 funds tracked by Wall St. Rank hold FHTX as of Q3 2026.

  • Empowered Funds held 70,500 shares of Foghorn Therapeutics worth $252K as of Q3 2026.
  • Foghorn Therapeutics was a new Empowered Funds position in Q3 2026.
  • Foghorn Therapeutics made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2121 holding.
  • 76 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.